5-Methylcytidine (m5C)-modified circSMAD2 promotes pancreatic cancer progression via the AKT/mTOR pathway
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Fields of Study & Subjects
Publication details
- Journal / source
- Genes & Diseases
- Pages
- 102156–102156
- Publication date
- 1 March 2026
- Language
- EN